What may be driving Eli Lilly shares lower — plus, oil and financial stocks rally

Market Update - Stocks are experiencing gains for the second consecutive session, with energy sector stocks, particularly Exxon Mobil and Chevron, benefiting from the anticipated rebuilding of Venezuela's oil infrastructure [1] - Financial stocks are also performing well, with Goldman Sachs, Wells Fargo, and Capital One reaching new highs [1] - BlackRock has outperformed, leading to a decision to sell part of the position to increase cash reserves [1] Health Care Sector - The health care sector is lagging behind the overall market rally, with major pharmaceutical and biotech companies like Eli Lilly, Bristol Myers, AbbVie, Johnson & Johnson, and Amgen seeing declines between 1% and 4% [1] - Eli Lilly's drop may be influenced by the launch of Novo Nordisk's oral GLP-1 weight loss pill in the U.S., with expectations for Lilly's own orforglipron launch in the first quarter, projected to generate $3.3 billion in sales [1] - The upcoming JPMorgan Healthcare Conference is a key event to watch, as it will feature presentations from health care companies in the portfolio, often providing updates on acquisitions, partnerships, and earnings preannouncements [1]